UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Use of miRNA Sequencing to Reveal Hub miRNAs and the Effect of miR-582-3p/SMAD2 in the Progression of Hepatocellular Carcinoma

Frontiers in genetics, 2022-03, Vol.13, p.819553

2022

Volltextzugriff (PDF)

Hydrostatic pressure induces osteogenic differentiation of adipose-derived mesenchymal stem cells through increasing lncRNA-PAGBC

Aging (Albany, NY.), 2020-07, Vol.12 (13), p.13477-13487

2020

Volltextzugriff (PDF)

Abstract 3632: Genomic profiling in circulating tumor DNA from Chinese advanced gastric adenocarcinomas patients

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.3632-3632

2020

Volltextzugriff (PDF)

Macro-Microporous Surface with Sulfonic Acid Groups and Micro-Nano Structures of PEEK/Nano Magnesium Silicate Composite Exhibiting Antibacterial Activity and Inducing Cell Responses

International journal of nanomedicine, 2020-01, Vol.15, p.2403-2417

2020

Volltextzugriff (PDF)

Zein regulating apatite mineralization, degradability, in vitro cells responses and in vivo osteogenesis of 3D-printed scaffold of n-MS/ZN/PCL ternary composite

RSC advances, 2018-05, Vol.8 (34), p.18745-18756

2018

Volltextzugriff (PDF)

A mercuric ensemble based on a cycloruthenated complex as a visual probe for iodide in aqueous solution

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2016-01, Vol.152, p.468-474

2016

Volltextzugriff (PDF)

Genome-wide characterization of lncRNAs in acute myeloid leukemia

Briefings in bioinformatics, 2018-07, Vol.19 (4), p.627-635

2018

Volltextzugriff (PDF)

Point Mutation of the Proteasome β5 Subunit Gene Is an Important Mechanism of Bortezomib Resistance in Bortezomib-Selected Variants of Jurkat T Cell Lymphoblastic Lymphoma/Leukemia Line

The Journal of pharmacology and experimental therapeutics, 2008-08, Vol.326 (2), p.423-431

2008

Volltextzugriff (PDF)

Bioactive and degradable scaffolds of the mesoporous bioglass and poly(l-lactide) composite for bone tissue regeneration

Journal of materials chemistry. B, Materials for biology and medicine, 2015-04, Vol.3 (15), p.2962-297

2015

Volltextzugriff (PDF)

Degradability, bioactivity, and osteogenesis of biocomposite scaffolds of lithium-containing mesoporous bioglass and mPEG-PLGA-b-PLL copolymer

International journal of nanomedicine, 2015-01, Vol.10 (default), p.4125-4136

2015

Volltextzugriff (PDF)

Overexpression of the PSMB5 gene contributes to bortezomib resistance in T-lymphoblastic lymphoma/leukemia cells derived from Jurkat line

Experimental hematology, 2008-10, Vol.36 (10), p.1278-1284

2008

Volltextzugriff (PDF)

SNX2-ABL1-positive acute lymphoblastic leukemia possibly has a poor prognosis

Leukemia & lymphoma, 2017-09, Vol.58 (9), p.2261-2263

2017

Volltextzugriff (PDF)

Continuous low-dose cyclophosphamide and prednisone in the treatment of relapsed/refractory multiple myeloma with severe heart failure

Leukemia & lymphoma, 2014-10, Vol.55 (10), p.2271-2276

2014

Volltextzugriff (PDF)

A combination of thalidomide and arsenic trioxide is effective and well tolerated in patients with myelodysplastic syndromes

Leukemia research, 2012-06, Vol.36 (6), p.715-719

2012

Volltextzugriff (PDF)

Mesoporous magnesium silicate-incorporated poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) bioactive composite beneficial to osteoblast behaviors

International journal of nanomedicine, 2014-05, Vol.9 (Issue 1), p.2665-2675

2014

Volltextzugriff (PDF)

Continuous Administration of Low-Dose Cyclophosphamide and Prednisone as a Salvage Treatment for Multiple Myeloma

Blood, 2009-11, Vol.114 (22), p.4962-4962

2009

Volltextzugriff (PDF)

Mesoporous magnesium silicate-incorporated poly bioactive composite beneficial to osteoblast behaviors

International journal of nanomedicine, 2014-01, Vol.9, p.2665

2014

Volltextzugriff (PDF)

Efficacy of continuous low-dose cyclophosphamide and prednisone regimen in refractory multiple myeloma patients with severe heart failure

Zhōnghuá xuèyèxué zázhì, 2015-03, Vol.36 (3), p.186

2015

Volltextzugriff (PDF)

Journal of Materials Chemistry B 3: Bioactive and degradable scaffolds of the mesoporous bioglass and poly composite for bone tissue regeneration

Cellular polymers, 2015-09, Vol.34 (5), p.270

2015

Volltextzugriff (PDF)

Continuous Administration of Low-Dose Cyclophosphamide and Prednisone as a Salvage Treatment for Multiple Myeloma

Clinical lymphoma, myeloma and leukemia, 2010-02, Vol.10 (1), p.51-55

2010

Volltextzugriff (PDF)

Point mutation of the proteasome beta5 subunit gene is an important mechanism of bortezomib resistance in bortezomib-selected variants of Jurkat T cell lymphoblastic lymphoma/leukemia line

The Journal of pharmacology and experimental therapeutics, 2008-08, Vol.326 (2), p.423

2008

Volltextzugriff (PDF)

SNX2-ABL1-positive acute lymphoblastic leukemia possibly has a poor prognosis

Leukemia & lymphoma, 2017, Vol.58 (9), p.1-3

2017

Volltextzugriff (PDF)

An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP+ mononuclear cells and PDGF-BB secretion

Bone Research, 2021-11, Vol.9 (1), p.47-47, Article 47

2021

Volltextzugriff (PDF)

Structural and Functional Analysis of the Costimulatory Receptor Programmed Death-1

Immunity (Cambridge, Mass.), 2004-03, Vol.20 (3), p.337-347

2004

Volltextzugriff (PDF)

Interaction of glioma-associated microglia/macrophages and anti-PD1 immunotherapy

Cancer Immunology, Immunotherapy, 2023-06, Vol.72 (6), p.1685-1698

2023

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(40)
Berichte
(1)

Sprache

Englisch
(39)
Chinesisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(23)
Humans
(14)
Animals
(10)
Mice
(8)
Oncology
(8)
Immunology
(7)
Biomedical Materials
(5)
Hematology
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Bones
(4)
Cells, Cultured
(4)
Female
(4)
Male
(4)
Original Research
(4)
Technology
(4)
Adult
(3)
Aged
(3)
Aged, 80 And Over
(3)
Antibodies
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Use of miRNA Sequencing to Reveal Hub miRNAs and the Effect of miR-582-3p/SMAD2 in the Progression of Hepatocellular Carcinoma

Hydrostatic pressure induces osteogenic differentiation of adipose-derived mesenchymal stem cells through increasing lncRNA-PAGBC

Abstract 3632: Genomic profiling in circulating tumor DNA from Chinese advanced gastric adenocarcinomas patients

Macro-Microporous Surface with Sulfonic Acid Groups and Micro-Nano Structures of PEEK/Nano Magnesium Silicate Composite Exhibiting Antibacterial Activity and Inducing Cell Responses

Zein regulating apatite mineralization, degradability, in vitro cells responses and in vivo osteogenesis of 3D-printed scaffold of n-MS/ZN/PCL ternary composite

A mercuric ensemble based on a cycloruthenated complex as a visual probe for iodide in aqueous solution

Genome-wide characterization of lncRNAs in acute myeloid leukemia

Point Mutation of the Proteasome β5 Subunit Gene Is an Important Mechanism of Bortezomib Resistance in Bortezomib-Selected Variants of Jurkat T Cell Lymphoblastic Lymphoma/Leukemia Line

Bioactive and degradable scaffolds of the mesoporous bioglass and poly(l-lactide) composite for bone tissue regeneration

Degradability, bioactivity, and osteogenesis of biocomposite scaffolds of lithium-containing mesoporous bioglass and mPEG-PLGA-b-PLL copolymer

Overexpression of the PSMB5 gene contributes to bortezomib resistance in T-lymphoblastic lymphoma/leukemia cells derived from Jurkat line

SNX2-ABL1-positive acute lymphoblastic leukemia possibly has a poor prognosis

Continuous low-dose cyclophosphamide and prednisone in the treatment of relapsed/refractory multiple myeloma with severe heart failure

A combination of thalidomide and arsenic trioxide is effective and well tolerated in patients with myelodysplastic syndromes

Mesoporous magnesium silicate-incorporated poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) bioactive composite beneficial to osteoblast behaviors

Continuous Administration of Low-Dose Cyclophosphamide and Prednisone as a Salvage Treatment for Multiple Myeloma

Mesoporous magnesium silicate-incorporated poly bioactive composite beneficial to osteoblast behaviors

Efficacy of continuous low-dose cyclophosphamide and prednisone regimen in refractory multiple myeloma patients with severe heart failure

Journal of Materials Chemistry B 3: Bioactive and degradable scaffolds of the mesoporous bioglass and poly composite for bone tissue regeneration

Continuous Administration of Low-Dose Cyclophosphamide and Prednisone as a Salvage Treatment for Multiple Myeloma

Point mutation of the proteasome beta5 subunit gene is an important mechanism of bortezomib resistance in bortezomib-selected variants of Jurkat T cell lymphoblastic lymphoma/leukemia line

SNX2-ABL1-positive acute lymphoblastic leukemia possibly has a poor prognosis

An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP+ mononuclear cells and PDGF-BB secretion

Structural and Functional Analysis of the Costimulatory Receptor Programmed Death-1

Interaction of glioma-associated microglia/macrophages and anti-PD1 immunotherapy

Suchergebnisse filtern